术中支持方式对肺移植术后原发性移植物功能障碍的影响
基于国际多中心注册研究,分析852例双肺移植中不同术中支持方式与重度原发性移植物功能障碍(PGD3)的关系。结果显示,CPB vs ECMO的OR为1.89,CPB vs 非体外循环的OR为4.24,ECMO vs 非体外循环的OR为2.24。结论认为ECMO较非体外循环增加PGD3风险,但低于CPB;需要体外生命支持时,ECMO可能是可优先考虑的方式。
要点
- PGD3发生率:非体外循环12.1%,ECMO 28.9%,CPB 42.7%。
- 校正后CPB vs ECMO的OR为1.89(95%CI 1.05-3.41;P=.033)。
- 校正后CPB vs 非体外循环OR为4.24(95%CI 2.24-8.04;P<.001),ECMO vs 非体外循环OR为2.24(95%CI 1.38-3.65;P=.001)。
核心结论
- 在高容量中心,静脉-动脉ECMO越来越多地用于支持复杂的双肺移植受者;该做法较非体外循环移植增加PGD3风险,但较CPB降低PGD3风险。
- 作者认为,当肺移植期间需要体外生命支持时,在可行的情况下ECMO可能是更可取的方式。
研究设计与样本
- 研究建立并分析了新型国际多中心注册研究——肺移植体外生命支持注册研究,纳入8个高容量中心(每年>40例)的双肺移植,排除多器官移植。
- 共分析2016年1月至2020年3月期间852例移植:非体外循环422例(50%),ECMO 273例(32%),CPB 157例(18%)。
- 重度PGD定义为再灌注后48或72小时观察到的3级PGD(PGD3)。
- 采用逐步混合选择多变量回归模型校正人口学和术中因素,最终模型纳入10个协变量。
主要发现
- 48-72小时时间点PGD3发生率:非体外循环12.1%(51/422),ECMO 28.9%(79/273),CPB 42.7%(67/157)。
- 校正后PGD3风险:CPB vs ECMO的OR为1.89(95%CI 1.05-3.41;P=.033)。
- 校正后PGD3风险:CPB vs 非体外循环的OR为4.24(95%CI 2.24-8.04;P<.001)。
- 校正后PGD3风险:ECMO vs 非体外循环的OR为2.24(95%CI 1.38-3.65;P=.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To clarify the relationship between the use of extracorporeal life support during lung transplantation and severe primary graft dysfunction (PGD), we developed and analyzed a novel multicenter international registry. METHODS: The Extracorporeal Life Support in Lung Transplantation Registry includes double-lung transplants performed at 8 high-volume centers (>40/year). Multiorgan transplants were excluded. We defined severe PGD as grade 3 PGD (PGD3) observed 48 or 72 hours after reperfusion. Modes of support were no extracorporeal life support (off-pump), extracorporeal membrane oxygenation (ECMO), and cardiopulmonary bypass (CPB). To assess the association between mode of support and PGD3, we adjusted for demographic and intraoperative factors with a stepwise, mixed selection, multivariable regression model, ending with 10 covariates in the final model. RESULTS: We analyzed 852 transplants performed between January 2016 and March 2020: 422 (50%) off-pump, 273 (32%) ECMO, and 157 (18%) CPB cases. PGD3 rates at time point 48-72 were 12.1% (51 out of 422) for off-pump, 28.9% for ECMO (79 out of 273), and 42.7% (67 out of 157) for CPB. The adjusted model resulted in the following risk profile for PGD3: CPB versus ECMO odds ratio, 1.89 (95% CI, 1.05-3.41; P = .033), CPB versus off-pump odds ratio, 4.24 (95% CI, 2.24-8.04; P < .001), and ECMO versus off-pump odds ratio, 2.24 (95% CI, 1.38-3.65; P = .001). CONCLUSIONS: Venoarterial ECMO is increasingly used at high-volume centers to support complex transplant recipients during double-lung transplantation. This practice is associated with more risk of PGD3 than off-pump transplantation but less risk than CPB. When extracorporeal life support is required during lung transplantation, ECMO may be the preferable approach when feasible.
引用
- Loor G, Huddleston S, Hartwig M, et al. Effect of mode of intraoperative support on primary graft dysfunction after lung transplant. J Thorac Cardiovasc Surg. 2022. PMID: 35236625. doi:10.1016/j.jtcvs.2021.10.076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。